Name: Latest research reports of Alkem Laboratories Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alkem Laboratories Ltd.
Rating: 1
Author: BOB Capital Markets Ltd.

Alkem Laboratories Ltd.

NSE: ALKEM | BSE: 539523 | ISIN: INE540L01014 | Industry: Pharmaceuticals
| Mid-range Performer

5388.5000 239.50 (4.65%)

NSE Aug 13, 2025 15:31 PM

Volume: 899.6K

High volume today

Alkem Laboratories Ltd.

08 Feb 2025

5388.50

4.65%

Alkem Labs (SELL): Slower growth in a seasonally strong quarter

Sell: Alkem Laboratories Ltd.

Recommendation Target

BOB Capital Markets Ltd.

Domestic sales were 6% below our estimates mainly due to slower recovery in the acute therapies and no price hike in NLEM portfolio

Number of FII/FPI investors increased from 535 to 551 in Jun 2025 qtr.